Dr Dima El-Sharkawi, WMUK trustee and Consultant Haematologist at the Royal Marsden Hospital, London, looks to answer some of the questions currently being asked of doctors and nurses in clinic consultations regarding how much people with WM should still be avoiding others.
On Friday 19 June, over 260 people joined our webinar, in partnership with Lymphoma Action, to hear our panel of UK experts answer some of the most commonly asked questions around COVID-19 and Waldenstrom's macroglobulinaemia (WM).
A recording of the webinar is now available here for those who were not able to join us on the day, or who wish to watch it again, along with answers to some of the questions not covered during the actual session.
WMUK Chief Executive, Lindsey Bennister said “We hope that the webinar was useful for people affected by WM. Following the success of this first session, we are now looking to host further webinars around this and other topics relevant for people affected by WM.
We would like to offer our sincere thanks to our panel of UK experts; Dr Shirley D’Sa and Helen DeMarco, our co-host Stephen Scowcroft and the team at Lymphoma Action, as well as everyone who participated in the webinar and submitted their questions to the panel in advance.